The S&P/ASX 200 Index (ASX: XJO) has followed the lead of international markets and is storming higher on Tuesday. In late morning trade the benchmark index is up 2% to 5,569.9 points following positive COVID19 vaccine news.

Four shares that are climbing more than most today are listed below. Here’s why they are jumping higher:

The James Hardie Industries plc (ASX: JHX) share price has stormed almost 11% higher to $23.75. Investors have been buying the building products company’s shares after the release of its full year results. James Hardie delivered a 4% increase in revenue to US$2.61 billion and a 20% lift in EBIT to US$486.8 million for the year ended March 31.

The Oil Search Limited (ASX: OSH) share price has jumped 9% to $3.27. The catalyst for this strong gain was a sharp rise in oil prices overnight. Traders appear optimistic that a vaccine could open up economies much quicker than expected and lead to an increase in demand for oil. The S&P/ASX 200 Energy index is up 4.5% at the time of writing.

The Webjet Limited (ASX: WEB) share price has surged 6% higher to $3.33. Once again, this strong gain appears to have been driven by the vaccine news. The travel sector would be a big winner if this vaccine solves the COVID19 crisis. It could mean that international travel returns much sooner than the market was expecting, which would only be good news for travel bookers like Webjet.

The Westpac Banking Corp (ASX: WBC) share price is up 4.5% to $15.58. Australia’s big four banks have responded very positively to today’s development and are all notably higher. If the crisis ends earlier than expected, it could mean the banks have all overestimated the provisions that will be required. This could have positive consequences for future dividend payments.

More reading

• This is the latest ASX 200 stock to unveil double digit profit growth
• 4 ASX 200 shares exposed to a fall in house prices
• 5 things to watch on the ASX 200 on Tuesday
• 3 industries that may never recover from COVID-19
• ASX 200 up 1.35%: Gold miners and Fortescue rocket higher, big four banks tumble

Motley Fool contributor James Mickleboro owns shares of Westpac Banking. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why James Hardie, Oil Search, Webjet, & Westpac shares are jumping higher appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2z2bcb8

In late morning trade positive COVID19 vaccine news has given the S&P/ASX 200 Index (ASX: XJO) a major lift. At the time of writing the benchmark index is up a sizeable 2% to 5,572.6 points.

Four shares that have failed to follow the market higher today are listed below. Here’s why they are tumbling lower:

The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price has fallen 2% to $27.82. Investors may believe that the prospect of a COVID19 vaccine being released in the near future will lead to a reduction in demand for this medical device company’s ventilators.

The Mesoblast limited (ASX: MSB) share price has crashed 8% lower to $3.82. This decline also appears to have been driven by the vaccine news. Mesoblast has been busy trialling its own treatment for COVID19, with promising results. If a vaccine is successful then there would arguably be little need for a treatment.

The Northern Star Resources Ltd (ASX: NST) share price is down over 3% to $14.14. Investors have been selling Northern Star and other gold miners today after a sharp pullback in the price of the precious metal. The prospect of a vaccine has given risk on assets a major boost and led to a fall in demand for safe haven assets.

The TechnologyOne Ltd (ASX: TNE) share price is down over 1.5% to $9.66. This enterprise software company’s shares were down as much as 5% following the release of its half year update. Investors appear underwhelmed by its 6% lift in sales and profits during the six months ending March 31. Especially given the significant premium of 52x trailing earnings that its shares trade at. TechnologyOne provided guidance for the full year and expects net profit before tax to increase 8% to 12% year on year.

More reading

• This ASX 200 tech share is sinking 5% lower after its half year update
• 5 things to watch on the ASX 200 on Tuesday
• Is it time to buy ASX 200 gold shares?
• 3 ASX 200 shares to watch this week
• ASX 200 Weekly Wrap: Gold miners help edge ASX ever higher

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why Fisher & Paykel Healthcare, Mesoblast, Northern Star, & TechnologyOne are tumbling lower appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2zRhOZG